medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Number 2

<< Back Next >>

Ann Hepatol 2012; 11 (2)

Increased mortality from acute liver failure in Mexico

Chávez-Tapia NC, Barrientos-Gutiérrez T, Guerrero-López CM, Santiago-Hernández JJ, Méndez-Sánchez N, Uribe M

Language: English
References: 21
Page: 257-262
PDF size: 306.63 Kb.


ABSTRACT

Introduction. There is significant geographic variation in the etiology and prognosis of acute liver failure (ALF). Since, little information is available for Latin America. We analyzed ALF mortality trends in Mexico. Material and methods. The rates of mortality attributable to ALF were obtained for 1998 to 2009 from the National System of Health Information in Mexico and analyzed according to date, etiology, sex, age and geographic characteristics through graphical assessment and joinpoint regression. Results. From 1998 to 2009, 2,193 ALF-related deaths were reported. A threefold increase in ALF mortality was observed during the period from 1998 to 2009 (the global mortality rate increased from 13.1 to 40.2 deaths per 10,000,000 inhabitants). The most significant increase was observed for viral etiologies after 2006, affecting people 45 years old and over. Conclusion. ALF-related deaths have increased since 2006. Although we cannot speculate on the specific causes of this increase, it may reflect improvements in the access of vulnerable populations to health care.


REFERENCES

  1. O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993: 342: 273-5.

  2. Nguyen NT, Vierling JM. Acute liver failure. Current opinion in organ transplantation 2011: 16: 289-96. Doi: 10.1097/MOT.0b013e328346c8ee.

  3. Bretherick AD, Craig DG, Masterton G, et al. Acute liver failure in Scotland between 1992 and 2009; incidence, aetiology and outcome. QJM: monthly journal of the Association of Physicians 2011. Doi: 10.1093/qjmed/hcr098.

  4. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010: 376: 190-201. Doi: 10.1016/S0140- 6736(10)60274-7.

  5. Nemes B, Zadori G, Gorog D, Fehervari I, Kobori L, Langer RM. Liver transplantation for acute liver failure: the Hungarian experience. Transplantation proceedings 2011: 43: 1278-80. Doi: 10.1016/j.transproceed.2011.03.076.

  6. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver transplantation 2000: 6: 163-9. Doi: 10.1002/lt.500060218.

  7. Pathikonda M, Munoz SJ. Acute liver failure. Ann Hepatal 2010: 9: 7-14.

  8. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine 2000: 19: 335-51.

  9. Dentovskaya SV, Anisimov AP, Kondakova AN, et al. Functional Characterization and Biological Significance of Yersinia pestis Lipopolysaccharide Biosynthesis Genes. Biochemistry. Biokhimiia 2011: 76: 808-22. Doi: 10.1134/ S0006297911070121.

  10. Moreira-Silva SF, Frauches DO, Almeida AL, Mendonca HF, Pereira FE. Acute liver failure in children: observations in Vitoria, Espirito Santo State, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 2002: 35: 483-6.

  11. Santos DC, Martinho JM, Pacheco-Moreira LF, et al. Fulminant hepatitis failure in adults and children from a Public Hospital in Rio de Janeiro, Brazil. Brazilian J Infect Dis 2009: 13: 323-9. Doi: 10.1590/S1413-86702009000500002.

  12. Ciocca M, Moreira-Silva SF, Alegria S, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatric Infect Dis J 2007: 26: 711-5. Doi: 10.1097/ INF.0b013e3180f60bed.

  13. Perdigón-Villaseñor G, Fernández-Cantón S. Evolución reciente del comportamiento de las hepatitis virales en México, 1990-2007. Bol Med Hosp Infant Mex 2009: 66: 204-7.

  14. Mendez-Sanchez N, Garcia-Villegas E, Merino-Zeferino B, et al. Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states. Ann Hepatol 2010: 9: 428-38.

  15. Case P, Ramos R, Brouwer KC, et al. At the borders, on the edge: use of injected methamphetamine in Tijuana and Ciudad Juarez, Mexico. J of Immigrant and minority health/Center for Minority Public Health 2008: 10: 23-33. Doi: 10.1007/s10903-007-9051-0.

  16. Girardi E, Scognamiglio P, Sciarrone MR, et al. High HIV prevalence in male patients with acute hepatitis A in the Rome metropolitan area, Italy 2002-2008. J Hepatol 2011: 54: 1102-6. Doi: 10.1016/j.jhep.2010.09.024.

  17. Barrientos-Gutierrez T, Brizuela-Alcantara D, Chavez-Tapia NC. Hepatitis A virus infection in high-risk subjects. Ann Hepatol 2011: 10: 578-9.

  18. Volkow P, Brouwer KC, Loza O, et al. Cross-border paid plasma donation among injection drug users in two Mexico- U.S. border cities. Inter J Drug Policy 2009: 20: 409-12. Doi: 10.1016/j.drugpo.2008.12.006.

  19. Oketani M, Ido A, Tsubouchi H. Changing etiologies and outcomes of acute liver failure: A perspective from Japan. J Gastroenterol and Hepatol 2011: 26(Suppl. 1): 65-71. Doi: 10.1111/j.1440-1746.2010.06574.x.

  20. Ajmera V, Xia G, Vaughan G, et al. What factors determine the severity of hepatitis A-related acute liver failure? J Viral Hepatitis 2011: 18: e167-74. Doi: 10.1111/j.1365- 2893.2010.01410.x.

  21. Merle U, Sieg O, Stremmel W, Encke J, Eisenbach C. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure. BMC Gastroenterology 2009: 9: 91. Doi: 10.1186/ 1471-230X-9-91.




2020     |     www.medigraphic.com